Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver

Shin‐ichi Kanamitsu(The University of Tokyo), Kiyomi Ito(Kitasato University), Yuichi Sugiyama(The University of Tokyo)
Pharmaceutical Research
March 1, 2000
10.1023/a:1007509324428
Cited by 133

Abstract

Related Papers

Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions
Richard Bertz, G. Richard Granneman|Clinical Pharmacokinetics|1997|752
Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver
Kikukatsu Ito, Takeshi Iwatsubo, Shin‐ichi Kanamitsu et al.|Pharmacological Reviews|1998|510
Methotrexate Pharmacokinetics
Kenneth B. Bischoff, Robert L. Dedrick, Daniel S. Zaharko et al.|Journal of Pharmaceutical Sciences|1971|478
Animal scale-up
Robert L. Dedrick|Journal of Pharmacokinetics and Biopharmaceutics|1973|394
QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORT
Ken Ito, Takeshi Iwatsubo, Shin-ichi Kanamitsu et al.|The Annual Review of Pharmacology and Toxicology|1998|279